Table1Chemical component of REISHI (% for dry matter)
Table2Free amino acid in REISHI (?mol/g for dry matter)
Table3Traditional pharmacological efficacy of REISHI(Data from an investigation by Y. NAOI, 1971~1981)
Table4Taste thresholds of bitter components
Table5Effects
of Ganoderans A and B on plasma glucose level in normal mice
Table6Effects
of Ganoderans A and B on plasma glucose level in Alloxan-induced
Table7Effects of Ganoderans B(Kyoto) and C on plasma glucoselevel in normal mice
Table8Hypoglycemic and antitumor activities of heteroglycans in REISHI
Table9Germanium
contents in crude drugs
Table10Mineral constituent and Ge-content in RIEISHI
Table11Ge-accumulation in REISHI
Table12Platelet aggregation inhibitors isolated from mushrooms
Table13Lectins isolated from mushrooms (42~73)
Table14Inhibition of hemagglutination of IRA by mono- andoligosaccharides
Table15Inhibition
of hemagglutination of GFL by mono-, oligosaccharidesand
Table16Host-mediated antitumor polysaccharides in REISHI
Table17Medium composition for the culture of Ganoderma lucidum
Table18Wheel
running performance data of the mice after 45 days of REISHI and water
drinking with training at 73-days-old
Table19Wheel
running performance data of the mice after 90 days of REISHI and water
drinking with training at 118-days-old
Table20Wheel
running performance data of the rats after REISHI and water drinking with
training at 73-days-old
Table21Wheel
running performance data of the rats after 90 days of REISHI and water
drinking with training at 118-days-old
Table22Tread-mill
running performance data of mice after 8-weeks of REISHI and water drinking
with training at 84-days-old
Table23
Tread-mill running performance data after 8 weeks of REISHI and water drinking
with training at 84-ays-old